UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000052827
Receipt number R000060250
Scientific Title A multicenter prospective cohort study for determining the optimal condition of observation for gastroesophageal junction (GOJ) in Upper esophagogastroduodenoscopy (EGD) under conscious situation
Date of disclosure of the study information 2023/11/17
Last modified on 2023/11/17 17:03:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A multicenter prospective cohort study for determining the optimal condition of observation for gastroesophageal junction (GOJ) in Upper esophagogastroduodenoscopy (EGD) under conscious situation

Acronym

GOJ-A

Scientific Title

A multicenter prospective cohort study for determining the optimal condition of observation for gastroesophageal junction (GOJ) in Upper esophagogastroduodenoscopy (EGD) under conscious situation

Scientific Title:Acronym

GOJ-A

Region

Japan


Condition

Condition

None

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the optimal condition of identification for the distal end of palisade vessels (DEPV) in upper EGD under conscious situation

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Rate of identification for DEPV visibility between under natural breathing and deep-inspirate breathing

Key secondary outcomes

Differences of identification of DEPV between patients with and without hiatal hernia in each with natural breathing and deep-inspirate breathing
Differences of identification of DEPV between patients with and without reflex esophagitis in each with natural breathing and deep-inspirate breathing
Differences of identification of DEPV between patients with and without Helicobacter pylori infection in each with natural breathing and deep-inspirate breathing
Differences of identification of DEPV depending on the degree of endoscopic gastric atrophy in each with natural breathing and under deep-inspirate breathing
Difference in DEPV visibility score between natural breathing and deep-inspirate breathing
Difference of PEGF visibility rate between natural breathing and deep-inspirate breathing
Concordance rate of DEPV and PEGF in each with natural breathing and deep-inspirate breathing
Intraobserver and interobserver agreement for visibility of DEPV
Factors associated with difficulties of identification of DEPV


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

(1) Patients in whom GOJ zone will be observed in upper EGD under conscious situation.
(2) Patients have received sufficient explanation about their participation in this study and have given informed consent written by themselves.

Key exclusion criteria

(1) Patients who refuse for participating in this study
(2) Patients with a history of surgical resection in upper gastrointestinal tract
(3) Patients who underwent endoscopic treatment in the GOJ zone (POEM, including balloon dilatation)
(4) Patients with suspected or present neoplastic lesions in the GOJ zone
(5) Patients with a confirmed diagnosis of esophageal motor dysfunction such as achalasia
(6) Patients who are judged as inappropriate for participating in this study by the researchers

Target sample size

500


Research contact person

Name of lead principal investigator

1st name Yoshimasa
Middle name
Last name Miura

Organization

Jichi Medical University

Division name

Department of Medicine, Division of Gastroenterology

Zip code

3290498

Address

3311-1, Yakushiji, Shimotsuke, Tochigi, Japan

TEL

+81285587348

Email

y-miura@jichi.ac.jp


Public contact

Name of contact person

1st name Takashi
Middle name
Last name Ueno

Organization

Jichi Medical University

Division name

Department of Medicine, Division of Gastroenterology

Zip code

329-0498

Address

3311-1, Yakushiji, Shimotsuke, Tochigi, Japan

TEL

+81285587348

Homepage URL


Email

m05012tu@jichi.ac.jp


Sponsor or person

Institute

Jichi Medical University

Institute

Department

Personal name



Funding Source

Organization

JDDW GOJZ consortium

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

the Ethics Committee of Jichi Medical University

Address

3311-1. Yakushiji, Shimotsuke, Tochigi

Tel

0285588933

Email

rinri@jichi.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 11 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2023 Year 11 Month 15 Day

Date of IRB

2023 Year 11 Month 15 Day

Anticipated trial start date

2023 Year 11 Month 20 Day

Last follow-up date

2026 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study is an exploratory study. Since there were no prior studies about this field, we decided the sample size from study period and the number of participating institutions. The sample size was set as 500.


Management information

Registered date

2023 Year 11 Month 17 Day

Last modified on

2023 Year 11 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000060250


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name